Manasson et al. reported IL-17 inhibitors-induced bacterial and fungal perturbations in psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients, which were more characterized by significant changes in Clostridiales and related taxa (Manasson et al., 2020). This evidence concerns the gene IL17A and spondyloarthropathy.